CRCHUM
Behavioural and Epidemiology Research Core
Epidemiology, HIV-HCV coinfection, Substance misuse

Centre de recherche du CHUM

Office R05-636

900 St Denis St,

Montreal, QC H2X 0A9

5148908000 ext 30903

Brendan completed his PhD through the Kirby Institute, UNSW Sydney in 2015, with a background in research and diagnostic laboratories in the blood borne virus field. The PhD project examined the molecular epidemiology of hepatitis C virus infection among people who inject drugs in Vancouver, Canada between 1996 and 2012. He is involved in many of the research projects withing the Kirby Institute's Viral Hepatitis Clinical Research Program Laboratory group, including characterizing viral and host mutations that infer resistance/susceptibility to treatment, and identifying transmission dynamics of hepatitis C virus (HCV) amongst HIV-positive and HIV-negative patients. Brendan has expanded on his laboratory research skills to include novel epidemiological methods to better understand the epidemiology of infectious diseases and substance misuse. Moving forward, Brendan will be examining the intersection of risk factors (including injecting practices and sexual behaviour) for HCV primary and secondary infection, and changes in patterns of drug use in local, regional and national contexts.